184 related articles for article (PubMed ID: 7931488)
1. Secondary malignancies after bone marrow transplantation in adults.
Lowsky R; Lipton J; Fyles G; Minden M; Meharchand J; Tejpar I; Atkins H; Sutcliffe S; Messner H
J Clin Oncol; 1994 Oct; 12(10):2187-92. PubMed ID: 7931488
[TBL] [Abstract][Full Text] [Related]
2. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.
Socié G; Curtis RE; Deeg HJ; Sobocinski KA; Filipovich AH; Travis LB; Sullivan KM; Rowlings PA; Kingma DW; Banks PM; Travis WD; Witherspoon RP; Sanders J; Jaffe ES; Horowitz MM
J Clin Oncol; 2000 Jan; 18(2):348-57. PubMed ID: 10637249
[TBL] [Abstract][Full Text] [Related]
3. Solid cancers after bone marrow transplantation.
Curtis RE; Rowlings PA; Deeg HJ; Shriner DA; Socíe G; Travis LB; Horowitz MM; Witherspoon RP; Hoover RN; Sobocinski KA; Fraumeni JF; Boice JD
N Engl J Med; 1997 Mar; 336(13):897-904. PubMed ID: 9070469
[TBL] [Abstract][Full Text] [Related]
4. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
[TBL] [Abstract][Full Text] [Related]
5. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation.
Rowlings PA; Curtis RE; Passweg JR; Deeg HJ; Socié G; Travis LB; Kingma DW; Jaffe ES; Sobocinski KA; Horowitz MM
J Clin Oncol; 1999 Oct; 17(10):3122-7. PubMed ID: 10506608
[TBL] [Abstract][Full Text] [Related]
8. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
9. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
Collins RH; Shpilberg O; Drobyski WR; Porter DL; Giralt S; Champlin R; Goodman SA; Wolff SN; Hu W; Verfaillie C; List A; Dalton W; Ognoskie N; Chetrit A; Antin JH; Nemunaitis J
J Clin Oncol; 1997 Feb; 15(2):433-44. PubMed ID: 9053463
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
[TBL] [Abstract][Full Text] [Related]
11. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
[TBL] [Abstract][Full Text] [Related]
13. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
[TBL] [Abstract][Full Text] [Related]
14. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.
Deeg HJ; Socié G; Schoch G; Henry-Amar M; Witherspoon RP; Devergie A; Sullivan KM; Gluckman E; Storb R
Blood; 1996 Jan; 87(1):386-92. PubMed ID: 8547667
[TBL] [Abstract][Full Text] [Related]
15. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.
Kolb HJ; Socié G; Duell T; Van Lint MT; Tichelli A; Apperley JF; Nekolla E; Ljungman P; Jacobsen N; van Weel M; Wick R; Weiss M; Prentice HG
Ann Intern Med; 1999 Nov; 131(10):738-44. PubMed ID: 10577296
[TBL] [Abstract][Full Text] [Related]
16. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
17. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.
Witherspoon RP; Fisher LD; Schoch G; Martin P; Sullivan KM; Sanders J; Deeg HJ; Doney K; Thomas D; Storb R
N Engl J Med; 1989 Sep; 321(12):784-9. PubMed ID: 2671734
[TBL] [Abstract][Full Text] [Related]
18. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation.
Hasegawa W; Pond GR; Rifkind JT; Messner HA; Lau A; Daly AS; Kiss TL; Kotchetkova N; Galal A; Lipton JH
Bone Marrow Transplant; 2005 Jan; 35(1):51-5. PubMed ID: 15516939
[TBL] [Abstract][Full Text] [Related]
20. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.
Radich JP; Sanders JE; Buckner CD; Martin PJ; Petersen FB; Bensinger W; McDonald GB; Mori M; Schoch G; Hansen JA
J Clin Oncol; 1993 Feb; 11(2):304-13. PubMed ID: 8426208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]